TIPSS for Variceal Bleeding in Patients with Idiopathic Non-Cirrhotic Portal Hypertension: Comparison with Patients Who Have Cirrhosis.
Yong Lv,Kai Li,Chuangye He,Bohan Luo,Bojing Zhang,Haibo Liu,Zhengyu Wang,Wengang Guo,Qiuhe Wang,Hui Chen,Wei Bai,Xulong Yuan,Tianlei Yu,Xiaomei Li,Jie Yuan,Na Han,Ying Zhu,Jing Niu,Huahong Xie,Jianhong Wang,Ling Chen,Zhanxin Yin,Daiming Fan,Zengshan Li,Guohong Han
DOI: https://doi.org/10.1111/apt.15186
IF: 9.524
2019-01-01
Alimentary Pharmacology & Therapeutics
Abstract:SummaryBackgroundIn patients with idiopathic non‐cirrhotic portal hypertension (INCPH), the usual recommended strategy for management of variceal bleeding is the same as that in cirrhosis. However, this policy has been challenged by the different natural history between INCPH and cirrhosis.AimTo compare outcomes after transjugular intrahepatic portosystemic shunt (TIPSS) between INCPH and cirrhotic patients admitted for variceal bleeding.MethodsBetween March 2001 and September 2015, 76 consecutive patients with biopsy‐proven INCPH undergoing TIPSS for variceal bleeding in a tertiary‐care centre were included. 76 patients with cirrhotic portal hypertension receiving TIPSS for variceal bleeding, and matched for age, sex, Child‐Pugh class, stent type and index year of TIPSS creation served as controls.ResultsPatients with INCPH, compared to those with cirrhosis, had significantly lower mortality (11% vs 36% at 5 years, adjusted HR, 0.37; 95% CI 0.15‐0.87, P = 0.022), overt hepatic encephalopathy (16% vs 33% at 5 years, adjusted HR, 0.35; 95% CI 0.16‐0.75, P = 0.007) and hepatic impairment, despite similar rates of further bleeding (33% vs 32% at 5 years, adjusted HR, 0.72; 95% CI 0.36‐1.44, P = 0.358), and shunt dysfunction (35% vs 36% at 5 years, adjusted HR, 0.84; 95% CI 0.41‐1.72, P = 0.627). These findings were consistent across different relevant subgroups.ConclusionsPatients with INCPH treated with TIPSS for variceal bleeding had similar progression of portal hypertension (further bleeding and shunt dysfunction) but fewer complications of liver disease (overt hepatic encephalopathy and hepatic insufficiency) and lower mortality rate compared with cirrhotic patients with comparable liver function.